AI Drug Discovery
The field of using artificial intelligence technology for drug discovery and development, covering molecular screening, target prediction, druggability optimization and related stages.
Timeline (last 90 days)
A "hit" by an AI model on a GPCR target generally refers to the early screening or binding validation stage, and reaching a clinical candidate compound still requires drug-likeness optimization and experimental validation.
AI mainly compresses the early-stage exploration cost of drug R&D (from years to months), rather than the entire R&D cycle; subsequently, cell experiments, animal experiments and multiple phases of clinical trials are still required, and the overall success rate remains very low.
The demand for computing power in AI drug discovery and precision medicine is growing exponentially.
All Facts (3)
A "hit" by an AI model on a GPCR target generally refers to the early screening or binding validation stage, and reaching a clinical candidate compound still requires drug-likeness optimization and experimental validation.
50%UnverifiedAI mainly compresses the early-stage exploration cost of drug R&D (from years to months), rather than the entire R&D cycle; subsequently, cell experiments, animal experiments and multiple phases of clinical trials are still required, and the overall success rate remains very low.
50%UnverifiedThe demand for computing power in AI drug discovery and precision medicine is growing exponentially.
50%